CASCADE: Agentic Framework Predicts Gene Perturbation Effects with Patient Data

There's a fresh preprint on arXiv (2608.05359) that unveils CASCADE, a new framework aimed at predicting how gene changes affect transcription using pre-made ARACNe regulatory networks analyzed through MCP. This approach goes beyond previous methods, which only verified if predicted genes belonged to known cancer gene lists, by checking if the predicted changes align with actual outcomes. It employs the amplification of focal-gene copy numbers as a stand-in for knockdown, validated against real tumor data from TCGA. For instance, CASCADE's predictions for MYC align closely with tumor expressions across three cancers: BRCA (90.0%), COAD (72.0%), and STAD (85.7%), all statistically significant. The findings hold up against PAM50 subtype controls and replicate in METABRIC (87.2%). Though compared to MSigDB gene-set baselines, CASCADE's accuracy doesn’t surpass existing data, it’s designed to autonomously navigate regulatory networks, offering potential advancements in precision oncology and drug discovery. The study highlights the need for validating computational predictions with patient data rather than just checking gene memberships.